Prostate Cancer Treatment Drugs Market Report

Global Prostate Cancer Treatment Drugs Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 11, 2022
  • PAGES：172
  • REPORT CODE：GMM810046
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Prostate Cancer Treatment Drugs market report explains the definition, types, applications, major countries, and major players of the Prostate Cancer Treatment Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Tolmar

    • Ipsen

    • AstraZeneca

    • Sanofi

    • Novartis

    • Abbott

    • Johnson & Johnson

    • Ferring Pharmaceuticals

    • Bayer

    • Astellas Pharma

    By Type:

    • Enzalutamid

    • Abiraterone

    • Leuprolide

    • Goserelin

    • Triptorelin

    • Histrelin

    • Degarelix

    • Docetaxel

    • Cabazitaxel

    By End-User:

    • Hospital

    • Research Institution

    • Clinic

    • Drugstore

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Prostate Cancer Treatment Drugs Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Prostate Cancer Treatment Drugs Outlook to 2028- Original Forecasts

    • 2.2 Prostate Cancer Treatment Drugs Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Prostate Cancer Treatment Drugs Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Prostate Cancer Treatment Drugs Market- Recent Developments

    • 6.1 Prostate Cancer Treatment Drugs Market News and Developments

    • 6.2 Prostate Cancer Treatment Drugs Market Deals Landscape

    7 Prostate Cancer Treatment Drugs Raw Materials and Cost Structure Analysis

    • 7.1 Prostate Cancer Treatment Drugs Key Raw Materials

    • 7.2 Prostate Cancer Treatment Drugs Price Trend of Key Raw Materials

    • 7.3 Prostate Cancer Treatment Drugs Key Suppliers of Raw Materials

    • 7.4 Prostate Cancer Treatment Drugs Market Concentration Rate of Raw Materials

    • 7.5 Prostate Cancer Treatment Drugs Cost Structure Analysis

      • 7.5.1 Prostate Cancer Treatment Drugs Raw Materials Analysis

      • 7.5.2 Prostate Cancer Treatment Drugs Labor Cost Analysis

      • 7.5.3 Prostate Cancer Treatment Drugs Manufacturing Expenses Analysis

    8 Global Prostate Cancer Treatment Drugs Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Prostate Cancer Treatment Drugs Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Prostate Cancer Treatment Drugs Export by Region (Top 10 Countries) (2017-2028)

    9 Global Prostate Cancer Treatment Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Prostate Cancer Treatment Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Enzalutamid Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Abiraterone Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Leuprolide Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Goserelin Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Triptorelin Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Histrelin Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Degarelix Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Docetaxel Consumption and Growth Rate (2017-2022)

      • 9.1.9 Global Cabazitaxel Consumption and Growth Rate (2017-2022)

    • 9.2 Global Prostate Cancer Treatment Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Research Institution Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Drugstore Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Prostate Cancer Treatment Drugs Market Analysis and Outlook till 2022

    • 10.1 Global Prostate Cancer Treatment Drugs Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.2.2 Canada Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.2.3 Mexico Prostate Cancer Treatment Drugs Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.3.2 UK Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.3.3 Spain Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.3.4 Belgium Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.3.5 France Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.3.6 Italy Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.3.7 Denmark Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.3.8 Finland Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.3.9 Norway Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.3.10 Sweden Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.3.11 Poland Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.3.12 Russia Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.3.13 Turkey Prostate Cancer Treatment Drugs Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.4.2 Japan Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.4.3 India Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.4.4 South Korea Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.4.5 Pakistan Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.4.6 Bangladesh Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.4.7 Indonesia Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.4.8 Thailand Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.4.9 Singapore Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.4.10 Malaysia Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.4.11 Philippines Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.4.12 Vietnam Prostate Cancer Treatment Drugs Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.5.2 Colombia Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.5.3 Chile Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.5.4 Argentina Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.5.5 Venezuela Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.5.6 Peru Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.5.7 Puerto Rico Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.5.8 Ecuador Prostate Cancer Treatment Drugs Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.6.2 Kuwait Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.6.3 Oman Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.6.4 Qatar Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Prostate Cancer Treatment Drugs Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.7.2 South Africa Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.7.3 Egypt Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.7.4 Algeria Prostate Cancer Treatment Drugs Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Prostate Cancer Treatment Drugs Consumption (2017-2022)

      • 10.8.2 New Zealand Prostate Cancer Treatment Drugs Consumption (2017-2022)

    11 Global Prostate Cancer Treatment Drugs Competitive Analysis

    • 11.1 Tolmar

      • 11.1.1 Tolmar Company Details

      • 11.1.2 Tolmar Prostate Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Tolmar Prostate Cancer Treatment Drugs Main Business and Markets Served

      • 11.1.4 Tolmar Prostate Cancer Treatment Drugs Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Ipsen

      • 11.2.1 Ipsen Company Details

      • 11.2.2 Ipsen Prostate Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Ipsen Prostate Cancer Treatment Drugs Main Business and Markets Served

      • 11.2.4 Ipsen Prostate Cancer Treatment Drugs Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 AstraZeneca

      • 11.3.1 AstraZeneca Company Details

      • 11.3.2 AstraZeneca Prostate Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 AstraZeneca Prostate Cancer Treatment Drugs Main Business and Markets Served

      • 11.3.4 AstraZeneca Prostate Cancer Treatment Drugs Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Sanofi

      • 11.4.1 Sanofi Company Details

      • 11.4.2 Sanofi Prostate Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Sanofi Prostate Cancer Treatment Drugs Main Business and Markets Served

      • 11.4.4 Sanofi Prostate Cancer Treatment Drugs Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Novartis

      • 11.5.1 Novartis Company Details

      • 11.5.2 Novartis Prostate Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Novartis Prostate Cancer Treatment Drugs Main Business and Markets Served

      • 11.5.4 Novartis Prostate Cancer Treatment Drugs Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Abbott

      • 11.6.1 Abbott Company Details

      • 11.6.2 Abbott Prostate Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Abbott Prostate Cancer Treatment Drugs Main Business and Markets Served

      • 11.6.4 Abbott Prostate Cancer Treatment Drugs Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Johnson & Johnson

      • 11.7.1 Johnson & Johnson Company Details

      • 11.7.2 Johnson & Johnson Prostate Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Johnson & Johnson Prostate Cancer Treatment Drugs Main Business and Markets Served

      • 11.7.4 Johnson & Johnson Prostate Cancer Treatment Drugs Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Ferring Pharmaceuticals

      • 11.8.1 Ferring Pharmaceuticals Company Details

      • 11.8.2 Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Main Business and Markets Served

      • 11.8.4 Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Bayer

      • 11.9.1 Bayer Company Details

      • 11.9.2 Bayer Prostate Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Bayer Prostate Cancer Treatment Drugs Main Business and Markets Served

      • 11.9.4 Bayer Prostate Cancer Treatment Drugs Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Astellas Pharma

      • 11.10.1 Astellas Pharma Company Details

      • 11.10.2 Astellas Pharma Prostate Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Astellas Pharma Prostate Cancer Treatment Drugs Main Business and Markets Served

      • 11.10.4 Astellas Pharma Prostate Cancer Treatment Drugs Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Prostate Cancer Treatment Drugs Market Outlook by Types and Applications to 2028

    • 12.1 Global Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Enzalutamid Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Abiraterone Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Leuprolide Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Goserelin Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Triptorelin Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Histrelin Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Degarelix Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.8 Global Docetaxel Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.9 Global Cabazitaxel Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Research Institution Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Drugstore Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Prostate Cancer Treatment Drugs Market Analysis and Outlook to 2028

    • 13.1 Global Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.2.2 Canada Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.3.2 UK Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.3.3 Spain Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.3.5 France Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.3.6 Italy Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.3.8 Finland Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.3.9 Norway Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.3.11 Poland Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.3.12 Russia Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.4.2 Japan Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.4.3 India Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.5.3 Chile Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.5.6 Peru Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.6.3 Oman Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Prostate Cancer Treatment Drugs Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Prostate Cancer Treatment Drugs

    • Figure of Prostate Cancer Treatment Drugs Picture

    • Table Global Prostate Cancer Treatment Drugs Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Prostate Cancer Treatment Drugs Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Enzalutamid Consumption and Growth Rate (2017-2022)

    • Figure Global Abiraterone Consumption and Growth Rate (2017-2022)

    • Figure Global Leuprolide Consumption and Growth Rate (2017-2022)

    • Figure Global Goserelin Consumption and Growth Rate (2017-2022)

    • Figure Global Triptorelin Consumption and Growth Rate (2017-2022)

    • Figure Global Histrelin Consumption and Growth Rate (2017-2022)

    • Figure Global Degarelix Consumption and Growth Rate (2017-2022)

    • Figure Global Docetaxel Consumption and Growth Rate (2017-2022)

    • Figure Global Cabazitaxel Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Research Institution Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Drugstore Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Treatment Drugs Consumption by Country (2017-2022)

    • Table North America Prostate Cancer Treatment Drugs Consumption by Country (2017-2022)

    • Figure United States Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Canada Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Mexico Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Prostate Cancer Treatment Drugs Consumption by Country (2017-2022)

    • Figure Germany Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure UK Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Spain Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Belgium Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure France Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Italy Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Denmark Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Finland Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Norway Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Sweden Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Poland Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Russia Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Turkey Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Table APAC Prostate Cancer Treatment Drugs Consumption by Country (2017-2022)

    • Figure China Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Thailand Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Singapore Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Philippines Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Table South America Prostate Cancer Treatment Drugs Consumption by Country (2017-2022)

    • Figure Brazil Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Colombia Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Chile Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Argentina Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Peru Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Table GCC Prostate Cancer Treatment Drugs Consumption by Country (2017-2022)

    • Figure Bahrain Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Oman Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Qatar Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Table Africa Prostate Cancer Treatment Drugs Consumption by Country (2017-2022)

    • Figure Nigeria Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Africa Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Egypt Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure Algeria Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Table Oceania Prostate Cancer Treatment Drugs Consumption by Country (2017-2022)

    • Figure Australia Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Prostate Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)

    • Table Tolmar Company Details

    • Table Tolmar Prostate Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tolmar Prostate Cancer Treatment Drugs Main Business and Markets Served

    • Table Tolmar Prostate Cancer Treatment Drugs Product Portfolio

    • Table Ipsen Company Details

    • Table Ipsen Prostate Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ipsen Prostate Cancer Treatment Drugs Main Business and Markets Served

    • Table Ipsen Prostate Cancer Treatment Drugs Product Portfolio

    • Table AstraZeneca Company Details

    • Table AstraZeneca Prostate Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Prostate Cancer Treatment Drugs Main Business and Markets Served

    • Table AstraZeneca Prostate Cancer Treatment Drugs Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Prostate Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Prostate Cancer Treatment Drugs Main Business and Markets Served

    • Table Sanofi Prostate Cancer Treatment Drugs Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Prostate Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Prostate Cancer Treatment Drugs Main Business and Markets Served

    • Table Novartis Prostate Cancer Treatment Drugs Product Portfolio

    • Table Abbott Company Details

    • Table Abbott Prostate Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Prostate Cancer Treatment Drugs Main Business and Markets Served

    • Table Abbott Prostate Cancer Treatment Drugs Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Prostate Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Prostate Cancer Treatment Drugs Main Business and Markets Served

    • Table Johnson & Johnson Prostate Cancer Treatment Drugs Product Portfolio

    • Table Ferring Pharmaceuticals Company Details

    • Table Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Main Business and Markets Served

    • Table Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Product Portfolio

    • Table Bayer Company Details

    • Table Bayer Prostate Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Prostate Cancer Treatment Drugs Main Business and Markets Served

    • Table Bayer Prostate Cancer Treatment Drugs Product Portfolio

    • Table Astellas Pharma Company Details

    • Table Astellas Pharma Prostate Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Prostate Cancer Treatment Drugs Main Business and Markets Served

    • Table Astellas Pharma Prostate Cancer Treatment Drugs Product Portfolio

    • Figure Global Enzalutamid Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Abiraterone Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Leuprolide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Goserelin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Triptorelin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Histrelin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Degarelix Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Docetaxel Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cabazitaxel Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Institution Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drugstore Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Treatment Drugs Consumption Forecast by Country (2022-2028)

    • Table North America Prostate Cancer Treatment Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Prostate Cancer Treatment Drugs Consumption Forecast by Country (2022-2028)

    • Figure Germany Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Prostate Cancer Treatment Drugs Consumption Forecast by Country (2022-2028)

    • Figure China Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Prostate Cancer Treatment Drugs Consumption Forecast by Country (2022-2028)

    • Figure Brazil Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Prostate Cancer Treatment Drugs Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Prostate Cancer Treatment Drugs Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Prostate Cancer Treatment Drugs Consumption Forecast by Country (2022-2028)

    • Figure Australia Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Prostate Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US